Abstract
Coronary artery disease (CAD) has become the most common cause of mortality in the entire world. Homocysteine is implicated as an early atherosclerotic promoter. We studied the relationship between levels of serum homocysteine with severity of coronary artery disease. Total of 70 subjects who scheduled for coronary angiogram consented to participate in this study. In all the patients Gensini scoring system was used to assess the severity of CAD. Venous samples were taken from the patients in fasting state before angiography. Homocysteine levels in patients were measured by enzyme linked immunosorbant method and were compared with respective Genseni scores of participants. Fasting serum homocysteine levels in CAD patients were significantly higher than patients without coronary artery disease (p < 0.001). Also Homocyseine levels correlated significantly with increasing severity of CAD (p < 0.001). Serum homocysteine levels correlated well with the severity of CAD.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Patil SS, Joshi R, Gupta G, Reddy MV, Pai M, Kalantri SP. Risk factors for acute myocardial infarction in a rural population of central India: a hospital-based case control study. Natl Med J India. 2004;17:189–94.
Goel PK, Bharti BB, Pandey CM, Singh U, Tewari S, Kapoor A, et al. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease. Ind Heart J. 2003;55:234–40.
Fuster V, Voute J. MDGs: chronic diseases are not on the agenda. Lancet. 2005;366(9496):1512–4.
Upadhyaya RP. An overview of the burden of non-communicable diseases in India. Iran J Public Health. 2012;41(3):1–8.
Goyal A, Yusuf S. The burden of cardiovascular disease in the Indian subcontinent. Indian J Med Res. 2006;124(3):235–44.
Smith SC Jr. Current and future directions of cardiovascular risk prediction. Am J Cardiol. 2006;97:28A–32A.
Mallinow MR. Hyperhomocysteinemia A common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81(6):2004–6.
Abraham R, Joseph John M, Calton R, Dhanoa J. Raised serum homocysteine levels in patients of coronary artery disease and the effect of vitamin B12 and folate on its concentration. Indian J Clin Biochem. 2006;21(1):95–100.
Chambers J, Obeid O, Refsum H, et al. Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men. Lancet. 2000;355(9203):523–7.
Refsum H. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6 Suppl):1731S–40S.
Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B12 status particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr. 2003;78(1):131–6.
Bissoli L, Di Francesco V, Ballarin A, Mandragona R, Trespidi R, Brocco G, et al. Effect of vegetarian diet on homocysteine levels. Ann Nutr Metab. 2002;46(2):73–79.
Verhoef P, Pasman W, Vleit T, Urgert R, Katan M. Contribution of caffeine to the homocysteine-raising effect of coffee: a randomized controlled trial in humans. Am J Clin Nutr. 2002;76(6):1244–8.
Tsiaras EM. Influence of smoking on predictors of vascular disease. Angiology. 2003;54(5):507–30.
Bazzano LA, He J, Muntner P, Vupputuri S, Whelton P. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138(11):891–7.
Mizrahi EH, Jacobsen DW, Debanne SM, Traore F, Lerner AJ, Friedland RP, Petot GJ. Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging. 2003;7(3):160–5.
Ward M. Homocysteine, folate and cardiovascular disease. Int J Vitam Nutr Res. 2001;71(3):173–8.
Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72(2):324–32.
Stampfer MJ, Malinow MR. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 1995;332:328–9.
Chai H, Chen Y, Chung S, Tsai T, Yong C, Chen H, et al. Value and level of plasma homocysteine in patients with angina pectoris undergoing coronary angiographic study. Int Heart J. 2011;52:280–5.
Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Study. JAMA. 1995;274:1526–33.
Bilsborough W, Green DJ, Mamotte CDS, van Bockxmeer FM, O’Driscoll GJ, Taylor RR. Endothelial nitric oxide synthase gene polymorphism, homocysteine, cholesterol and vascular endothelial function. Atherosclerosis. 2003;169(1):131–8.
Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation. 1999;100(11):1161–8.
Cavalca V, Cighetti G, Bamonti F, Loaldi A, Bortone L, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem. 2001;47(5):887–92.
Mirdamadi A, Farzamnia H, Varzandeh P, Almasi N, Arasteh M. Association between serum homocysteine concentration with coronary artery disease in Iranian patients. ARYA Atheroscler. 2011;7(2):63–7.
Acknowledgement
We are grateful to our Dean, Kasturba Medical College, Manipal University, Manipal for providing support to conduct study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shenoy, V., Mehendale, V., Prabhu, K. et al. Correlation of Serum Homocysteine Levels with the Severity of Coronary Artery Disease. Ind J Clin Biochem 29, 339–344 (2014). https://doi.org/10.1007/s12291-013-0373-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-013-0373-5